Paul joined GARDP as the Australian Representative in January 2018, bringing over 25 years of experience in the biotechnology industry.
He was previously a life sciences specialist at Austrade, the Australian Government’s trade and investment promotion agency, where he facilitated commercial partnerships around Australian research into malaria, dengue fever, schistosomiasis, and other neglected tropical diseases as well as the development of novel antimicrobials. Earlier, Paul was the Executive Chairman of Bio-Link, a privately-owned biotechnology business development company with offices in Melbourne and Sydney. His work at Bio-Link involved the commercialization of discovery, pre-clinical, and early-stage clinical programs in oncology, neurology, infectious diseases, and other therapeutic areas.
Paul has served as a non-executive director on a number of different Boards including the Advisory Board of the Global Health Alliance Melbourne.